Webinar to explore impact of AI ‘Super Agents’ on healthcare

AI Super Agents: What They Are and Their Potential Global Health Impact

Artificial General Intelligence (AGI) represents a significant advancement in AI, with the potential to create systems that can learn, reason, and solve problems across various fields — potentially in ways that exceed human capabilities.

Opinions differ on the timeline for AGI development. Sam Altman of OpenAI suggests AGI could arrive this year, while others believe it remains distant.

Regardless of when AGI emerges, AI is becoming increasingly sophisticated.

Notably, AI agents with reasoning and decision-making abilities, especially ‘Super Agents,’ are being utilised across numerous domains, including healthcare.

In this Webinar, hosted by Feminnovation Events, experts will:

• Define Super AI
• Explore the current status of AGI development
• Examine how AI Agents are influencing healthcare and women’s health

AI Super Agents: What They Are and Their Potential Global Health Impact

Session date: Wednesday, February 12, 2025 6:00 PM
Duration: 1 hour 0 minutes
Timezone: Europe/London

Webinar Topics

Understanding Agentic AI and AGI: What are they, how do they function, and is AGI on the horizon?

Applications of Agentic AI in Healthcare: Current deployments and the most promising uses

Opportunities and Challenges of Agentic AI and AGI in Health: Potential benefits and risks, including in women’s health

Exploring Future Impact: Which areas of healthcare might see significant effects from Agentic AI in the near-term? What role might AGI play, and could it replace healthcare professionals?

Q&A Session: Answering your questions

Speakers

Eric Eskioglu, MD Entrepreneur in Residence at HMA The Academy (WCAS); Senior Partner at CSuite Growth Advisors

Mr. Eskioglu is former executive vice president and chief medical, scientific & innovation officer for Novant Health. In 2022, he was recognized by Modern Healthcare Magazine as “Top 50 Most Influential Clinical Executives” and “Top 25 Innovators.”

He obtained his MBA at Vanderbilt in 2022 and was recognized by National Poets & Quants Society as one of the top 100 Executive MBA’s of 2022. At Novant Health he provided operational, strategic, clinical, and cultural leadership to ensure the delivery of high-quality, cost-effective, and patient-centered care across Novant Health.

Dr. Eskioglu oversaw all medical staff and lead the safety and quality teams and initiatives. In addition, he was the leader of 8 Novant Health Clinical Institutes, Novant Health Research Institute, Pharmacy with its entire P&L, healthcare economics group as well as Co-Executive Director for Novant’s Institute of Innovation and Artificial Intelligence.

  Robin Farmanfarmaian Entrepreneur and Co-Author of “How AI Can Democratize Healthcare: The Rise in Digital Care”

Robin Farmanfarmaian is a professional speaker and healthcare entrepreneur working with cutting-edge Artificial Intelligence Software, Device and Pharma companies poised to impact 100M patients. She has written 4 books, including “The Patient as CEO: How Technology Empowers the Healthcare Consumer& (2015) and “How AI Can Democratize Healthcare: The Rise in Digital Care” (2022).

She is involved with over 20 early-stage biotech and healthcare startups and an advisor to multiple companies, including: Luxsonic Technologies, portable radiology reading room in VR; Alacrity Care, remote patient monitoring and data analytics for oncology; and ConceptVines, a VC fund and product engineering firm focused on disruptive tech.